Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin

Details for Australian Patent Application No. 2002245551 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Ajani, Jafferhusen A.; Dugan, Terry S.; Benner, Steven E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002245551

PCT Pub. Number WO2002/076459

Priority 60/273,577 06.03.01 US

Filing date 4 March 2002

Wipo publication date 8 October 2002

International Classifications

A61K 031/505 - Pyrimidines

A61K 031/335 - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 031/175

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002245551

25 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245552-FLUORESCENCE DETECTOR GEOMETRY

2002245550-METHOD FOR MINIMIZING BETA GLUCAN PROBLEMS IN BEER BREWING